ANIP vs. CRDO

Last updated Apr 2, 2026

Compare and contrast key facts about ANI Pharmaceuticals, Inc. (ANIP) and Credo Technology Group Holding Ltd (CRDO).

Performance

ANIP vs. CRDO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ANI Pharmaceuticals, Inc. (ANIP) and Credo Technology Group Holding Ltd (CRDO). The values are adjusted to include any dividend payments, if applicable.

ANIP vs. CRDO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
ANIP ANI Pharmaceuticals, Inc.	-3.78%	42.80%	0.25%	37.06%	-0.54%
CRDO Credo Technology Group Holding Ltd	-33.34%	114.09%	245.20%	46.28%	14.25%

Fundamentals

Market Cap ANIP : $1.61B CRDO : $17.90B
EPS ANIP : $3.75 CRDO : $1.84
PE Ratio ANIP : 20.24 CRDO : 52.14
PEG Ratio ANIP : 0.14 CRDO : 0.03
PS Ratio ANIP : 1.80 CRDO : 16.59
PB Ratio ANIP : 2.98 CRDO : 9.68
Total Revenue (TTM) ANIP : $883.37M CRDO : $1.07B
Gross Profit (TTM) ANIP : $610.19M CRDO : $724.47M
EBITDA (TTM) ANIP : $225.70M CRDO : $340.31M

Returns By Period

In the year-to-date period, ANIP achieves a -3.78% return, which is significantly higher than CRDO's -33.34% return.

ANIP

• 1D: -1.22%
• 1M: 0.98%
• YTD: -3.78%
• 6M: -15.76%
• 1Y: 11.67%
• 3Y*: 24.12%
• 5Y*: 17.42%
• 10Y*: 8.39%

CRDO

• 1D: 2.18%
• 1M: -16.02%
• YTD: -33.34%
• 6M: -33.81%
• 1Y: 129.91%
• 3Y*: 116.75%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ANIP vs. CRDO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANIP

ANIP Risk / Return Rank: 50
ANIP Sharpe Ratio Rank: 52
ANIP Sortino Ratio Rank: 49
ANIP Omega Ratio Rank: 47
ANIP Calmar Ratio Rank: 52
ANIP Martin Ratio Rank: 51

CRDO

CRDO Risk / Return Rank: 81
CRDO Sharpe Ratio Rank: 85
CRDO Sortino Ratio Rank: 81
CRDO Omega Ratio Rank: 77
CRDO Calmar Ratio Rank: 82
CRDO Martin Ratio Rank: 81

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANIP vs. CRDO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ANI Pharmaceuticals, Inc. (ANIP) and Credo Technology Group Holding Ltd (CRDO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ANIP	CRDO	Difference
Sharpe ratio Return per unit of total volatility	0.32	1.56	-1.24
Sortino ratio Return per unit of downside risk	0.80	2.18	-1.38
Omega ratio Gain probability vs. loss probability	1.10	1.27	-0.17
Calmar ratio Return relative to maximum drawdown	0.47	2.59	-2.12
Martin ratio Return relative to average drawdown	0.94	6.61	-5.67
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ANIP vs. CRDO - Sharpe Ratio Comparison

The current ANIP Sharpe Ratio is 0.32, which is lower than the CRDO Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of ANIP and CRDO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ANIP	CRDO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.32	1.56	-1.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.37	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.17	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	0.82	-0.88

Correlation

The correlation between ANIP and CRDO is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ANIP vs. CRDO - Dividend Comparison

Neither ANIP nor CRDO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ANIP vs. CRDO - Drawdown Comparison

The maximum ANIP drawdown since its inception was -98.81%, which is greater than CRDO's maximum drawdown of -62.04%. Use the drawdown chart below to compare losses from any high point for ANIP and CRDO.

Drawdown Indicators

	ANIP	CRDO	Difference
Max Drawdown Largest peak-to-trough decline	-98.81%	-62.04%	-36.77%
Max Drawdown (1Y) Largest decline over 1 year	-28.66%	-53.59%	+24.93%
Max Drawdown (5Y) Largest decline over 5 years	-59.38%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-72.96%	—	—
Current Drawdown Current decline from peak	-83.12%	-49.30%	-33.82%
Average Drawdown Average peak-to-trough decline	-79.38%	-19.76%	-59.62%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.29%	21.00%	-6.71%

Volatility

ANIP vs. CRDO - Volatility Comparison

The current volatility for ANI Pharmaceuticals, Inc. (ANIP) is 9.46%, while Credo Technology Group Holding Ltd (CRDO) has a volatility of 26.22%. This indicates that ANIP experiences smaller price fluctuations and is considered to be less risky than CRDO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ANIP	CRDO	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.46%	26.22%	-16.76%
Volatility (6M) Calculated over the trailing 6-month period	22.61%	63.19%	-40.58%
Volatility (1Y) Calculated over the trailing 1-year period	36.90%	83.94%	-47.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.03%	80.30%	-33.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.61%	80.30%	-31.69%

Financials

ANIP vs. CRDO - Profitability Comparison

The chart below illustrates the profitability comparison between ANI Pharmaceuticals, Inc. and Credo Technology Group Holding Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ANIP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ANI Pharmaceuticals, Inc. reported a gross profit of 237.56M and revenue of 247.06M. Therefore, the gross margin over that period was 96.2%.

CRDO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Credo Technology Group Holding Ltd reported a gross profit of 278.87M and revenue of 407.01M. Therefore, the gross margin over that period was 68.5%.

ANIP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ANI Pharmaceuticals, Inc. reported an operating income of 48.18M and revenue of 247.06M, resulting in an operating margin of 19.5%.

CRDO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Credo Technology Group Holding Ltd reported an operating income of 149.62M and revenue of 407.01M, resulting in an operating margin of 36.8%.

ANIP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ANI Pharmaceuticals, Inc. reported a net income of 29.97M and revenue of 247.06M, resulting in a net margin of 12.1%.

CRDO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Credo Technology Group Holding Ltd reported a net income of 157.14M and revenue of 407.01M, resulting in a net margin of 38.6%.